Article Results (Showing 1 - 10 of 10) RSS Alert
-
Manifestations of Cutaneous Sarcoidosis: A Case Report of an African American Woman
Financial Support: Speakers' bureau memberships include Amgen Inc and Wyeth Pharmaceuticals. Current consulting/ advisory board agreements include:...
Journal of the National Medical Association, 06/01/09 by Zhang, Jing X; Kerbleski, Joseph F; Gottlieb, Alice B · More from publication -
Successful treatment of disseminated granuloma annulare with adalimumab
ABSTRACT ABSTRACT A 61-year-old-female with a 4-year history of disseminated granuloma annulare was successfully treated with the antitumor...
Journal of Drugs in Dermatology, 02/01/09 by David Rosmarin; Anne LaRaia; Scott Schlauder; Alice B. Gottlieb · More from publication -
Adverse drug events in infliximab-treated patients compared with the general and psoriasis populations
ABSTRACT ABSTRACT Introduction: Infliximab is indicated for severe plaque psoriasis (PsO). The investigators compared safety event rates in...
Journal of Drugs in Dermatology, 12/01/08 by Alan Menter; Kristian Reich; Alice B. Gottlieb; Mohan Bala; Shu Li; Ming-Chun Hsu; Cynthia Guzzo; Joris Diels; Joel M. Gelfand · More from publication -
Refractory dissecting cellulitis of the scalp treated with adalimumab
ABSTRACT ABSTRACT Dissecting cellulitis of the scalp (DCS) is a suppurative, neutrophilic dermatosis. Therapies typically provide short-term...
Journal of Drugs in Dermatology, 10/01/08 by Smita V. Sukhatme; Yolanda M. Lenzy; Alice B. Gottlieb · More from publication -
Psoriasis and the metabolic syndrome
Abstract Abstract Psoriasis is a chronic immune-inflammatory-mediated disease that can predispose patients to other inflammatory conditions....
Journal of Drugs in Dermatology, 06/01/08 by Alice B. Gottlieb · More from publication -
Safety and efficacy of alefacept in elderly patients and other special populations
Abstract Abstract Background: The safety of biologic agents for psoriasis treatment is of particular importance in patient groups at higher...
Journal of Drugs in Dermatology, 11/01/05 by Alice B. Gottlieb · More from publication -
Extended efalizumab therapy sustains efficacy without increasing toxicity in patients with moderate to severe chronic plaque psoriasis
Abstract Abstract Agents that safely provide long-term control of psoriasis are needed. To determine the safety and efficacy of extended...
Journal of Drugs in Dermatology, 11/01/04 by Alice B. Gottlieb · More from publication -
The National Psoriasis Foundation Psoriasis Score System versus the Psoriasis Area Severity Index and Physician's Global Assessment : a comparison
Abstract Abstract The Psoriasis Area and Severity Index (PASI) and Physician Global Assessment (PGA) are commonly used, but fail to measure...
Journal of Drugs in Dermatology, 06/01/03 by Alice B Gottlieb · More from publication -
Psoriatic arthritis: a guide for dermatology nurses
Psoriatic arthritis (PsA) affects people in the prime of life, causing functional impairment and diminished quality of life. Etanercept, the first...
Dermatology Nursing, 04/01/03 by Alice B. Gottlieb · More from publication -
Treating psoriasis patients
Psoriasis is a serious disease. Approximately 7% of psoriasis patients aged 1854 years actively contemplate suicide because of their condition. And...
Skin & Allergy News, 06/01/02 by Alice B. Gottlieb · More from publication
